Price Move History
- Daily moves over 5%
- 131 198 sessions, November 11, 2024 to November 11, 2025
- Largest daily move
- +1000% close of July 25, 2025
- 1-year change
- -99.7% closing prices, November 11, 2024 to November 11, 2025
- 1-month change
- +0% closing prices, October 10, 2025 to November 11, 2025
Company Description
4Front Ventures Corp. (FFNTF) is described as a national, vertically integrated multi-state cannabis operator. The company is associated with the cannabis industry and is classified in the medicinal and botanical manufacturing space within the broader manufacturing sector. According to company disclosures, 4Front has focused on cultivation, production, and retail operations in the United States.
4Front states that it operates in Illinois and Massachusetts and has facilities in Washington. The company highlights experience in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. Over its history, 4Front reports that it has brought to market more than 20 cannabis brands and over 1,800 products, which it distributes through its fully owned and operated Mission-branded dispensaries and other retail outlets in its core markets.
The company traces its origins to its founding in 2011. Over time, it has emphasized low-cost cultivation and production methodologies and describes a track record in building and operating cannabis facilities. Its operations have included wholesale activities and retail channels in markets where cannabis is regulated at the state level.
Business model and operations
Based on the company’s own descriptions in its news releases, 4Front’s business model has combined cultivation and manufacturing of cannabis products with retail distribution. The company notes that its products are sold through Mission dispensaries and other retail outlets in its core markets. It also references wholesale activities, particularly in Massachusetts and Illinois, and has discussed cultivation and production facilities that support both wholesale and retail channels.
4Front has reported that it operates a large cultivation and production facility in Matteson, Illinois, which it has described as a key part of its expansion in that state. The company has also referred to facilities in Washington and operations in Massachusetts, indicating a multi-state footprint within the U.S. cannabis sector.
Recent corporate and legal developments
In 2025, 4Front announced a series of significant developments affecting its corporate and financial status. On May 22, 2025, all U.S. subsidiaries of 4Front filed for voluntary receivership in aid of liquidation under the laws of the Commonwealth of Massachusetts. The filings were made in the Business Litigation Session of the Superior Court for Suffolk County in case number 2584CV01405. The company stated that it intended to continue operating during the receivership process while pursuing an orderly sale of its subsidiaries’ assets.
On June 20, 2025, the court entered an order appointing Opus Consulting Partners, LLC, through its principal, as Receiver for the subsidiaries and their associated assets. The Receiver was granted authority to operate, manage, and pursue the sale of the subsidiaries with the stated goal of maximizing value for creditors and stakeholders. The Receiver was also authorized to engage a senior strategic consultant and advisor in connection with this process.
Separately, 4Front disclosed that it made an assignment into bankruptcy pursuant to the Canadian Bankruptcy and Insolvency Act. The company reported that B. Riley Farber was appointed as trustee in those Canadian bankruptcy proceedings. In another disclosure, 4Front noted that the Ontario Securities Commission issued a failure-to-file cease trade order against the company after it did not file audited annual financial statements and related disclosures for the year ended December 31, 2024, by the required deadline.
4Front has also indicated that, due to filing deficiencies and the receivership petition, it anticipates that its securities will ultimately be delisted from the Canadian Securities Exchange and the OTCQB. These developments mean that investors researching FFNTF should understand that the company is subject to receivership and bankruptcy processes and that trading in its securities has been restricted in certain jurisdictions.
Geographic footprint and activities
According to its public statements, 4Front’s core U.S. operations have been in Illinois and Massachusetts, with additional facilities in Washington. The company has described a 250,000 square foot cultivation and production facility in Matteson, Illinois, and has characterized Illinois as a key growth market. It has also referred to wholesale and retail activities in Massachusetts and to operations in Washington that have contributed to its revenue.
4Front’s Mission-branded dispensaries and retail outlets have been used to distribute its portfolio of cannabis brands and products in its core markets. The company has also discussed wholesale channels in Massachusetts and Illinois, indicating that its business has combined both direct-to-consumer retail and business-to-business wholesale components.
Status considerations for investors
Given the voluntary receivership of all U.S. subsidiaries, the Canadian bankruptcy proceedings, and the failure-to-file cease trade order issued by the Ontario Securities Commission, 4Front Ventures Corp. is in a distressed and restructuring context. The company has publicly stated that the receivership is intended to facilitate an orderly sale of its subsidiaries’ businesses or assets. It has also acknowledged that, as a result of these developments and filing deficiencies, its securities are expected to be delisted from the Canadian Securities Exchange and the OTCQB.
These disclosures mean that FFNTF represents a company undergoing court-supervised processes in multiple jurisdictions. Anyone examining FFNTF stock should review the latest court documents, regulatory orders, and company announcements to understand the implications for ownership interests, potential recoveries, and ongoing operations.
Stock Performance
4FRONT VENTURES (FFNTF) closed at $0.0001 on November 11, 2025. Over the past 12 months, the price has lost 99.7%.
FFNTF Metrics & Rankings
Price returns through November 11, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
4FRONT VENTURES has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include management, earnings, conferences. View all FFNTF news →
SEC Filings
Short Interest History
Short interest in 4FRONT VENTURES (FFNTF) currently stands at 100 shares.
Days to Cover History
Days to cover for 4FRONT VENTURES (FFNTF) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
FFNTF Company Profile & Sector Positioning
4FRONT VENTURES (FFNTF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing FFNTF often look at related companies in the same sector, including UBIQUITECH SOFTWARE CORP (UBQU), SOHM INC (SHMN), TILT HLDGS INC (TLLTF), WEED INC (BUDZ), and LFTD PARTNERS INC (LIFD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FFNTF's relative position within its industry.